SLC1A5 and melanoma: In addition, miR-137 inhibits ferroptosis by targeting SLC1A5 in A375 and G-361 melanoma cells in a glutaminolysis-dependent manner, thus inhibiting Gln uptake, while SLC1A5 overexpression can reverse the suppression effect on ferroptosis (Luo et al., 2018).